IMMUTEP ADR |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.98 USD | +3.83% |
|
+4.93% | +24.17% |
| 05-17 | Capital One Initiates Immutep at Overweight Rating With $10 Price Target | MT |
| 05-15 | Immutep Says Safety Lead-in Phase of Breast Cancer Study Yields 'Encouraging' Data | MT |
6877ec327a3.qgUIQq94KpS6K2ufCeItAOtHz7S_uc-n9gR7LaDXiiE.-HddB5kzXayMTgP4Z7hmcrQjgI3M65nmmSkIf-mw8HT9NWUVmDVY2YNqLg~0069794f3702ae2317bf871be0298018